TNFR1 is essential for CD40, but not for lipopolysaccharide-induced sickness behavior and clock gene dysregulation

Advani, 2009, Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin’s lymphoma, J. Clin. Oncol., 27, 4371, 10.1200/JCO.2008.21.3017 Balasa, 1997, CD40 ligand–CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice, J. Immunol., 159, 4620, 10.4049/jimmunol.159.9.4620 Bluthe, 2000, Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice, Eur. J. Neurosci., 12, 4447 Boggio, 2003, Cerebroventricular administration of interferon-gamma modifies locomotor activity in the golden hamster, Neurosignals, 12, 89, 10.1159/000071818 Burgos, 2009, Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII, Arthritis Rheum., 61, 1179, 10.1002/art.24649 Cavadini, 2007, TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription, Proc. Natl. Acad. Sci. USA, 104, 12843, 10.1073/pnas.0701466104 Danese, 2004, The CD40/CD40L costimulatory pathway in inflammatory bowel disease, Gut, 53, 1035, 10.1136/gut.2003.026278 Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat. Rev. Neurosci., 9, 46, 10.1038/nrn2297 De La Garza, 2005, Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia, Neurosci. Biobehav. Rev., 29, 761, 10.1016/j.neubiorev.2005.03.016 Dinarello, 2009, Immunological and inflammatory functions of the interleukin-1 family, Annu. Rev. Immunol., 27, 519, 10.1146/annurev.immunol.021908.132612 Durie, 1993, Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40, Science, 261, 1328, 10.1126/science.7689748 Elgueta, 2009, Molecular mechanism and function of CD40/CD40L engagement in the immune system, Immunol. Rev., 229, 152, 10.1111/j.1600-065X.2009.00782.x Etchegaray, 2003, Rhythmic histone acetylation underlies transcription in the mammalian circadian clock, Nature, 421, 177, 10.1038/nature01314 Farahani, 2006, Community-based evaluation of etanercept in patients with rheumatoid arthritis, J. Rheumatol., 33, 665 Furman, 2010, A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia, Leuk. Lymphoma, 51, 228, 10.3109/10428190903440946 Grewal, 1998, CD40 and CD154 in cell-mediated immunity, Annu. Rev. Immunol., 16, 111, 10.1146/annurev.immunol.16.1.111 Haller, 2003, Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation, J. Biol. Chem., 278, 23851, 10.1074/jbc.M300075200 Hart, 1988, Biological basis of the behavior of sick animals, Neurosci. Biobehav. Rev., 12, 123, 10.1016/S0149-7634(88)80004-6 Hastings, 2003, A clockwork web: circadian timing in brain and periphery, in health and disease, Nat. Rev. Neurosci., 4, 649, 10.1038/nrn1177 Howard, 1999, Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis, J. Clin. Invest., 103, 281, 10.1172/JCI5388 Hussein, M., Berenson, J.R., Niesvizky, R., Munshi, N., Matous, J., Sobecks, R., Harrop, K., Drachman, J.G., Whiting, N., 2010. A phase 1 multidose study of dacetuzumab (SGN-40; humanized anti-CD40 mAb) in patients with multiple myeloma. Haematologica. Imeri, 2009, How (and why) the immune system makes us sleep, Nat. Rev. Neurosci., 10, 199, 10.1038/nrn2576 Katz, 2009, Patient-reported outcomes following biologic therapy in a sample of adults with rheumatoid arthritis recruited from community-based rheumatologists, Arthritis Rheum., 61, 593, 10.1002/art.24511 King, 2000, Molecular genetics of circadian rhythms in mammals, Annu. Rev. Neurosci., 23, 713, 10.1146/annurev.neuro.23.1.713 Konsman, 2002, Cytokine-induced sickness behaviour: mechanisms and implications, Trends Neurosci., 25, 154, 10.1016/S0166-2236(00)02088-9 Kwak, 2008, Interferon-gamma alters electrical activity and clock gene expression in suprachiasmatic nucleus neurons, J. Biol. Rhythms, 23, 150, 10.1177/0748730407313355 Leon, 1997, Exacerbated febrile responses to LPS, but not turpentine, in TNF double receptor-knockout mice, Am. J. Physiol., 272, R563 Lichtenstein, 2002, Infliximab improves quality of life in patients with Crohn’s disease, Inflamm. Bowel Dis., 8, 237, 10.1097/00054725-200207000-00001 Liu, 2000, Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40–CD154 interactions, J. Immunol., 164, 6005, 10.4049/jimmunol.164.11.6005 Majde, 2005, Links between the innate immune system and sleep, J. Allergy Clin. Immunol., 116, 1188, 10.1016/j.jaci.2005.08.005 Mohan, 1995, Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis, J. Immunol., 154, 1470, 10.4049/jimmunol.154.3.1470 Moreland, 2006, Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis, Arthritis Rheum., 55, 287, 10.1002/art.21838 Ohdo, 2001, Changing the dosing schedule minimizes the disruptive effects of interferon on clock function, Nat. Med., 7, 356, 10.1038/85507 Okada, 2008, Injection of LPS causes transient suppression of biological clock genes in rats, J. Surg. Res., 145, 5, 10.1016/j.jss.2007.01.010 Palin, 2009, The type 1 TNF receptor and its associated adapter protein, FAN, are required for TNFalpha-induced sickness behavior, Psychopharmacology (Berlin), 201, 549, 10.1007/s00213-008-1331-4 Petrzilka, 2009, Clock gene modulation by TNF-alpha depends on calcium and p38 MAP kinase signaling, J. Biol. Rhythms, 24, 283, 10.1177/0748730409336579 Preitner, 2002, The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator, Cell, 110, 251, 10.1016/S0092-8674(02)00825-5 Qin, 2006, IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3, J. Immunol., 177, 7761, 10.4049/jimmunol.177.11.7761 Reppert, 2002, Coordination of circadian timing in mammals, Nature, 418, 935, 10.1038/nature00965 Ripperger, 2006, Rhythmic CLOCK–BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions, Nat. Genet., 38, 369, 10.1038/ng1738 Ripperger, 2000, CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP, Genes Dev., 14, 679, 10.1101/gad.14.6.679 Schibler, 2009, The 2008 Pittendrigh/Aschoff lecture: peripheral phase coordination in the mammalian circadian timing system, J. Biol. Rhythms, 24, 3, 10.1177/0748730408329383 Schibler, 2002, A web of circadian pacemakers, Cell, 111, 919, 10.1016/S0092-8674(02)01225-4 Shang, 2000, Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription, Cell, 103, 843, 10.1016/S0092-8674(00)00188-4 Shinohara, 2008, Dosing schedule-dependent change in the disruptive effects of interferon-alpha on the circadian clock function, Life Sci., 83, 574, 10.1016/j.lfs.2008.08.005 Taylor, 2009, Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis, Nat. Rev. Rheumatol., 5, 578, 10.1038/nrrheum.2009.181 Teeling, 2007, Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines, Brain Behav. Immun., 21, 836, 10.1016/j.bbi.2007.01.012 Tench, 2000, The prevalence and associations of fatigue in systemic lupus erythematosus, Rheumatology (Oxford), 39, 1249, 10.1093/rheumatology/39.11.1249 Tollner, 2000, The role of tumor necrosis factor (TNF) in the febrile and metabolic responses of rats to intraperitoneal injection of a high dose of lipopolysaccharide, Pflugers Arch., 440, 925, 10.1007/s004240000386 Tyring, 2006, Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial, Lancet, 367, 29, 10.1016/S0140-6736(05)67763-X van Hoogmoed, D., Fransen, J., Bleijenberg, G., van Riel, P., 2010. Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford). Wierda, 2000, CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia, Blood, 96, 2917, 10.1182/blood.V96.9.2917